Home›People›Stanley Lapidus
SL

Stanley Lapidus

Director at Lucid Diagnostics. Also a director at SunBird Bio.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Feb 24, 2026·Suggest an edit

About Stanley Lapidus

Stanley Lapidus is a director at Lucid Diagnostics.

Form D filings name Stanley Lapidus as a director at SunBird Bio.

Stanley Lapidus reports to the SEC as a director of 2 public companies, including T2 Biosystems (TTOO).

Stanley Lapidus first appears on SEC filings in 2016.

Experience

This experience comes from SEC filings. The years are when the filings name Stanley Lapidus in the role, so the role may have started earlier or lasted longer.

Lucid Diagnostics Inc.
Director
2021 – 2026 · Public company (LUCD)
SunBird Bio, Inc.
Director
2020 – 2023 · Cambridge, MA
T2 Biosystems, Inc.
Director
2016 – 2019 · Public company (TTOO)

Key Colleagues at Startups

The people Stanley Lapidus works with at each company, as listed on that company's latest Form D.

SunBird Bio, Inc. · Form D, May 12, 2023
JM
YW
Yingmin Wang
Director
HS
Huilin Shao
Director
SK
Steve Kafka
Director

Sources

  1. SECSunBird Bio, Inc. Form D, filed May 12, 2023
  2. SECForms 3, 4 and 5 filed by Stanley Lapidus (SEC filer 1678195)